JPRN-jRCT2031230570招募中1 期
Phase I Clinical Study of JTE-052 new drug product - Dermal Safety Study
Koretomo Ryosuke0 个研究点目标入组 22 人开始时间: 2024年1月16日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 发起方
- 入组人数
- 22
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 <= 45age old（—）
- 性别
- Male
入选标准
- •1.Healthy Japanese males aged from 20 to 45 years
- •2.Those with a body mass index (BMI) of 18.5 to less than 25.0
排除标准
- •1.Those who have skin conditions that may affect the evaluation in the study, e.g., eczema, dermatitis, pigmentation abnormality, inflammation caused by sunburn, injury, scar, and excessive hair growth, at the prospective application site
- •2.Those who have a history of contact dermatitis caused by dermatological drugs, adhesive plaster, tape, etc. mechanical urticaria, dermal hypersensitivity, or atopic dermatitis
- •3.Those to whom JTE-052 has been administered in the past
- •4.Those for whom the investigator judged it problematic to participate in the study
研究者
相似试验
已完成
不适用
Exporatory clinical study for newly developed drug therapy for preeclampsia with oral nicotinamidepreeclampsiaJPRN-UMIN000029418Tohoku University6
已完成
1 期
Phase-I Clinical Trial to study the Safety of oral drug Bioplatin in patients of Advanced metastatic Solid Tumours and those who are resistant to conventional treatmentsCTRI/2017/06/008778Rasayani Biologics Pvt Ltd14
未知
1 期
Phase I/II clinical trial of inactivated HVJ-E administration for advanced malignant melanoma patientsJPRN-UMIN000002376Department of Dermatology Osaka University Graduate School of Medicine6
招募中
1 期
Phase I/II trial for safety and pharmacokinetics of ENDOPIN in healthy adults and patients with paiPhase 1 part: Healthy adult male Phase 2 part: Postoperative pain patientspostoperative painD010149JPRN-jRCT2051220144akajima Takako46
招募中
2 期
Dose finding study of JTE-051Interstitial Cystitis/Bladder Pain SyndromeJPRN-jRCT2031210042Koretomo Ryosuke150